Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene
Identifieur interne : 000A44 ( France/Analysis ); précédent : 000A43; suivant : 000A45Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene
Auteurs : C. Bonnet [France] ; S. Krieger [France] ; M. Vezain [France] ; A. Rousselin [France] ; I. Tournier [France] ; A. Martins [France] ; P. Berthet [France] ; A. Chevrier [France] ; C. Dugast [France] ; V. Layet [France] ; A. Rossi [France] ; R. Lidereau [France] ; T. Frébourg [France] ; A. Hardouin [France] ; M. Tosi [France]Source :
- Journal of Medical Genetics [ 0022-2593 ] ; 2008-07.
Abstract
Background: Many unclassified variants (UV) of BRCA1 or BRCA2 may have an effect on pre-mRNA splicing. Patient blood samples suitable for RNA extraction are not always available for testing UVs at the RNA level. Methods: Analyses of RNA from patient peripheral blood were performed, using a one-step reverse transcriptase-PCR (RT-PCR) protocol, and were compared with an ex vivo splicing assay based on PCR-amplified patient DNA inserted into a splicing reporter minigene. Using both methods 20 variants found in 17 patients were examined. Results: Data from patient RNA and from the minigene assay were fully concordant, but the ex vivo splicing assay, which is monoallelic, clarified several ambiguities in the patient RNA data. Two intronic variants induced strong splicing defects: BRCA1 c.4987-5T→A (IVS16-5T→A) induced exon 17 skipping and BRCA2 c.316+5G→C (IVS3+5G→C) induced complete skipping of exon 3. Of the exonic variants, BRCA2 c.7805G→C (p.Arg2602Thr), at the last base of exon 16, induced both exon skipping and activation of a cryptic exonic donor site, and BRCA2 c.8023A→G (p.Ile2675Val) generated a strong donor site within exon 18. These four variants were thus classified as pathogenic, because of the total absence of a normal transcript from the corresponding allele. Variant BRCA2 c.9501+3A→T (IVS25+3A→T) induced incomplete skipping of exon 25, suggesting a mutation with incomplete penetrance, and BRCA2 c.8257_8259del (p.Leu2753del) modified the alternative splicing of exons 17 and 18. Conclusions: We show that functional analysis using a splicing reporter minigene is sensitive and specific, and should be used for initial screening of potential splicing defects, especially when patient RNA is not readily available.
Url:
DOI: 10.1136/jmg.2007.056895
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001189
- to stream Istex, to step Curation: 001189
- to stream Istex, to step Checkpoint: 000368
- to stream Main, to step Merge: 000E07
- to stream Main, to step Curation: 000D96
- to stream Main, to step Exploration: 000D96
- to stream France, to step Extraction: 000A44
Links to Exploration step
ISTEX:A9A887E1E6B0F98F5398F6D5E73424FF2F713F23Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene</title><author><name sortKey="Bonnet, C" sort="Bonnet, C" uniqKey="Bonnet C" first="C" last="Bonnet">C. Bonnet</name></author><author><name sortKey="Krieger, S" sort="Krieger, S" uniqKey="Krieger S" first="S" last="Krieger">S. Krieger</name></author><author><name sortKey="Vezain, M" sort="Vezain, M" uniqKey="Vezain M" first="M" last="Vezain">M. Vezain</name></author><author><name sortKey="Rousselin, A" sort="Rousselin, A" uniqKey="Rousselin A" first="A" last="Rousselin">A. Rousselin</name></author><author><name sortKey="Tournier, I" sort="Tournier, I" uniqKey="Tournier I" first="I" last="Tournier">I. Tournier</name></author><author><name sortKey="Martins, A" sort="Martins, A" uniqKey="Martins A" first="A" last="Martins">A. Martins</name></author><author><name sortKey="Berthet, P" sort="Berthet, P" uniqKey="Berthet P" first="P" last="Berthet">P. Berthet</name></author><author><name sortKey="Chevrier, A" sort="Chevrier, A" uniqKey="Chevrier A" first="A" last="Chevrier">A. Chevrier</name></author><author><name sortKey="Dugast, C" sort="Dugast, C" uniqKey="Dugast C" first="C" last="Dugast">C. Dugast</name></author><author><name sortKey="Layet, V" sort="Layet, V" uniqKey="Layet V" first="V" last="Layet">V. Layet</name></author><author><name sortKey="Rossi, A" sort="Rossi, A" uniqKey="Rossi A" first="A" last="Rossi">A. Rossi</name></author><author><name sortKey="Lidereau, R" sort="Lidereau, R" uniqKey="Lidereau R" first="R" last="Lidereau">R. Lidereau</name></author><author><name sortKey="Frebourg, T" sort="Frebourg, T" uniqKey="Frebourg T" first="T" last="Frébourg">T. Frébourg</name></author><author><name sortKey="Hardouin, A" sort="Hardouin, A" uniqKey="Hardouin A" first="A" last="Hardouin">A. Hardouin</name></author><author><name sortKey="Tosi, M" sort="Tosi, M" uniqKey="Tosi M" first="M" last="Tosi">M. Tosi</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A9A887E1E6B0F98F5398F6D5E73424FF2F713F23</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1136/jmg.2007.056895</idno><idno type="url">https://api.istex.fr/document/A9A887E1E6B0F98F5398F6D5E73424FF2F713F23/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001189</idno><idno type="wicri:Area/Istex/Curation">001189</idno><idno type="wicri:Area/Istex/Checkpoint">000368</idno><idno type="wicri:doubleKey">0022-2593:2008:Bonnet C:screening:brca:and</idno><idno type="wicri:Area/Main/Merge">000E07</idno><idno type="wicri:Area/Main/Curation">000D96</idno><idno type="wicri:Area/Main/Exploration">000D96</idno><idno type="wicri:Area/France/Extraction">000A44</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene</title><author><name sortKey="Bonnet, C" sort="Bonnet, C" uniqKey="Bonnet C" first="C" last="Bonnet">C. Bonnet</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Inserm U614, IFRMP, Faculty of Medicine and Department of Genetics, University Hospital, Institute for Biomedical Research, Rouen</wicri:regionArea><placeName><settlement type="city">Rouen</settlement></placeName></affiliation></author><author><name sortKey="Krieger, S" sort="Krieger, S" uniqKey="Krieger S" first="S" last="Krieger">S. Krieger</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen</wicri:regionArea><placeName><settlement type="city">Caen</settlement></placeName></affiliation></author><author><name sortKey="Vezain, M" sort="Vezain, M" uniqKey="Vezain M" first="M" last="Vezain">M. Vezain</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Inserm U614, IFRMP, Faculty of Medicine and Department of Genetics, University Hospital, Institute for Biomedical Research, Rouen</wicri:regionArea><placeName><settlement type="city">Rouen</settlement></placeName></affiliation></author><author><name sortKey="Rousselin, A" sort="Rousselin, A" uniqKey="Rousselin A" first="A" last="Rousselin">A. Rousselin</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen</wicri:regionArea><placeName><settlement type="city">Caen</settlement></placeName></affiliation></author><author><name sortKey="Tournier, I" sort="Tournier, I" uniqKey="Tournier I" first="I" last="Tournier">I. Tournier</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Inserm U614, IFRMP, Faculty of Medicine and Department of Genetics, University Hospital, Institute for Biomedical Research, Rouen</wicri:regionArea><placeName><settlement type="city">Rouen</settlement></placeName></affiliation></author><author><name sortKey="Martins, A" sort="Martins, A" uniqKey="Martins A" first="A" last="Martins">A. Martins</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Inserm U614, IFRMP, Faculty of Medicine and Department of Genetics, University Hospital, Institute for Biomedical Research, Rouen</wicri:regionArea><placeName><settlement type="city">Rouen</settlement></placeName></affiliation></author><author><name sortKey="Berthet, P" sort="Berthet, P" uniqKey="Berthet P" first="P" last="Berthet">P. Berthet</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Consultation d’Oncogénétique, Centre François Baclesse, Caen</wicri:regionArea><placeName><settlement type="city">Caen</settlement></placeName></affiliation></author><author><name sortKey="Chevrier, A" sort="Chevrier, A" uniqKey="Chevrier A" first="A" last="Chevrier">A. Chevrier</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Unité de Génétique Clinique, CHU de Rouen</wicri:regionArea><wicri:noRegion>CHU de Rouen</wicri:noRegion><wicri:noRegion>CHU de Rouen</wicri:noRegion></affiliation></author><author><name sortKey="Dugast, C" sort="Dugast, C" uniqKey="Dugast C" first="C" last="Dugast">C. Dugast</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Consultation d’Oncogénétique, Centre Eugène Marquis et CHU, Rennes</wicri:regionArea><placeName><settlement type="city">Rennes</settlement></placeName></affiliation></author><author><name sortKey="Layet, V" sort="Layet, V" uniqKey="Layet V" first="V" last="Layet">V. Layet</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Unité de Génétique, Hôpital Flaubert, Le Havre</wicri:regionArea><placeName><settlement type="city">Le Havre</settlement></placeName></affiliation></author><author><name sortKey="Rossi, A" sort="Rossi, A" uniqKey="Rossi A" first="A" last="Rossi">A. Rossi</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Unité de Génétique Clinique, CHU de Rouen</wicri:regionArea><wicri:noRegion>CHU de Rouen</wicri:noRegion><wicri:noRegion>CHU de Rouen</wicri:noRegion></affiliation></author><author><name sortKey="Lidereau, R" sort="Lidereau, R" uniqKey="Lidereau R" first="R" last="Lidereau">R. Lidereau</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Centre René Huguenin, FNCLCC, Inserm U735, St-Cloud</wicri:regionArea><wicri:noRegion>St-Cloud</wicri:noRegion><wicri:noRegion>St-Cloud</wicri:noRegion></affiliation></author><author><name sortKey="Frebourg, T" sort="Frebourg, T" uniqKey="Frebourg T" first="T" last="Frébourg">T. Frébourg</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Inserm U614, IFRMP, Faculty of Medicine and Department of Genetics, University Hospital, Institute for Biomedical Research, Rouen</wicri:regionArea><placeName><settlement type="city">Rouen</settlement></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Unité de Génétique Clinique, CHU de Rouen</wicri:regionArea><wicri:noRegion>CHU de Rouen</wicri:noRegion><wicri:noRegion>CHU de Rouen</wicri:noRegion></affiliation></author><author><name sortKey="Hardouin, A" sort="Hardouin, A" uniqKey="Hardouin A" first="A" last="Hardouin">A. Hardouin</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen</wicri:regionArea><placeName><settlement type="city">Caen</settlement></placeName></affiliation></author><author><name sortKey="Tosi, M" sort="Tosi, M" uniqKey="Tosi M" first="M" last="Tosi">M. Tosi</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Inserm U614, IFRMP, Faculty of Medicine and Department of Genetics, University Hospital, Institute for Biomedical Research, Rouen</wicri:regionArea><placeName><settlement type="city">Rouen</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Medical Genetics</title><title level="j" type="abbrev">J Med Genet</title><idno type="ISSN">0022-2593</idno><idno type="eISSN">1468-6244</idno><imprint><publisher>BMJ Publishing Group Ltd</publisher><date type="published" when="2008-07">2008-07</date><biblScope unit="volume">45</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="438">438</biblScope></imprint><idno type="ISSN">0022-2593</idno></series><idno type="istex">A9A887E1E6B0F98F5398F6D5E73424FF2F713F23</idno><idno type="DOI">10.1136/jmg.2007.056895</idno><idno type="href">jmedgenet-45-438.pdf</idno><idno type="ArticleID">mg56895</idno><idno type="PMID">18424508</idno><idno type="local">jmedgenet;45/7/438</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-2593</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Background: Many unclassified variants (UV) of BRCA1 or BRCA2 may have an effect on pre-mRNA splicing. Patient blood samples suitable for RNA extraction are not always available for testing UVs at the RNA level. Methods: Analyses of RNA from patient peripheral blood were performed, using a one-step reverse transcriptase-PCR (RT-PCR) protocol, and were compared with an ex vivo splicing assay based on PCR-amplified patient DNA inserted into a splicing reporter minigene. Using both methods 20 variants found in 17 patients were examined. Results: Data from patient RNA and from the minigene assay were fully concordant, but the ex vivo splicing assay, which is monoallelic, clarified several ambiguities in the patient RNA data. Two intronic variants induced strong splicing defects: BRCA1 c.4987-5T→A (IVS16-5T→A) induced exon 17 skipping and BRCA2 c.316+5G→C (IVS3+5G→C) induced complete skipping of exon 3. Of the exonic variants, BRCA2 c.7805G→C (p.Arg2602Thr), at the last base of exon 16, induced both exon skipping and activation of a cryptic exonic donor site, and BRCA2 c.8023A→G (p.Ile2675Val) generated a strong donor site within exon 18. These four variants were thus classified as pathogenic, because of the total absence of a normal transcript from the corresponding allele. Variant BRCA2 c.9501+3A→T (IVS25+3A→T) induced incomplete skipping of exon 25, suggesting a mutation with incomplete penetrance, and BRCA2 c.8257_8259del (p.Leu2753del) modified the alternative splicing of exons 17 and 18. Conclusions: We show that functional analysis using a splicing reporter minigene is sensitive and specific, and should be used for initial screening of potential splicing defects, especially when patient RNA is not readily available.</div></front></TEI><affiliations><list><country><li>France</li></country><settlement><li>Caen</li><li>Le Havre</li><li>Rennes</li><li>Rouen</li></settlement></list><tree><country name="France"><noRegion><name sortKey="Bonnet, C" sort="Bonnet, C" uniqKey="Bonnet C" first="C" last="Bonnet">C. Bonnet</name></noRegion><name sortKey="Berthet, P" sort="Berthet, P" uniqKey="Berthet P" first="P" last="Berthet">P. Berthet</name><name sortKey="Chevrier, A" sort="Chevrier, A" uniqKey="Chevrier A" first="A" last="Chevrier">A. Chevrier</name><name sortKey="Dugast, C" sort="Dugast, C" uniqKey="Dugast C" first="C" last="Dugast">C. Dugast</name><name sortKey="Frebourg, T" sort="Frebourg, T" uniqKey="Frebourg T" first="T" last="Frébourg">T. Frébourg</name><name sortKey="Frebourg, T" sort="Frebourg, T" uniqKey="Frebourg T" first="T" last="Frébourg">T. Frébourg</name><name sortKey="Hardouin, A" sort="Hardouin, A" uniqKey="Hardouin A" first="A" last="Hardouin">A. Hardouin</name><name sortKey="Krieger, S" sort="Krieger, S" uniqKey="Krieger S" first="S" last="Krieger">S. Krieger</name><name sortKey="Layet, V" sort="Layet, V" uniqKey="Layet V" first="V" last="Layet">V. Layet</name><name sortKey="Lidereau, R" sort="Lidereau, R" uniqKey="Lidereau R" first="R" last="Lidereau">R. Lidereau</name><name sortKey="Martins, A" sort="Martins, A" uniqKey="Martins A" first="A" last="Martins">A. Martins</name><name sortKey="Rossi, A" sort="Rossi, A" uniqKey="Rossi A" first="A" last="Rossi">A. Rossi</name><name sortKey="Rousselin, A" sort="Rousselin, A" uniqKey="Rousselin A" first="A" last="Rousselin">A. Rousselin</name><name sortKey="Tosi, M" sort="Tosi, M" uniqKey="Tosi M" first="M" last="Tosi">M. Tosi</name><name sortKey="Tournier, I" sort="Tournier, I" uniqKey="Tournier I" first="I" last="Tournier">I. Tournier</name><name sortKey="Vezain, M" sort="Vezain, M" uniqKey="Vezain M" first="M" last="Vezain">M. Vezain</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A44 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000A44 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/France
|area= LeHavreV1
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:A9A887E1E6B0F98F5398F6D5E73424FF2F713F23
|texte= Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene
}}
| This area was generated with Dilib version V0.6.25. |  |